Prophylaxis of thromboembolic events during urologic surgery

被引:7
作者
Cittanova-Pansard, ML
Droupy, S
Susen, S
Boiteux, JP
Marret, E
Laversin, S
Doublet, JD
机构
[1] Hop Tenon, Serv Urol, F-75020 Paris, France
[2] Hop Prive Antony, Serv Anesthesie Reanimat, F-96166 Antony, France
[3] Hop Bicetre, Serv Urol, F-94270 Le Kremlin Bicetre, France
[4] CHU Lille, Lab Hematol, Hop Cardiol, F-59037 Lille, France
[5] Hop Gabriel Montpied, Serv Urol, F-63000 Clermont Ferrand, France
[6] Hop Tenon, Serv Anesthesie Reanimat, F-75020 Paris, France
[7] Haute Autorite Sante, F-93218 St Denis, France
[8] Hop Tenon, Serv Urol, F-75020 Paris, France
来源
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 2005年 / 24卷 / 08期
关键词
urology; antithrombotic prophylaxis; thromboembolic event; endoscopic urology;
D O I
10.1016/j.annfar.2005.05.013
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Few scientific evidences are available in the literature, and the methodologic quality of the studies is often under average. Nevertheless, the conclusions are the following. Nephrectomy, renal transplantation, open surgery of the lower urinary tract and lumbar or pelvic lymph nodes dissection are at high risk for thromboembolic events. Other open or endoscopic urological procedures are at low risk. The laparoscopic approach doesn't change the risk associated with the procedure itself. Thromboprophylaxis is recommended in high-risk procedures. There was no evidence to recommend starting the prophylaxis before more than after the procedure. The use of low molecular weight heparin is recommended for prophylaxis. It can be associated with compressive stockings. It is recommended to treat for around seven days after the procedure. In case of cancer surgery, prophylaxis could be needed for four to six weeks. (c) 2005 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:902 / 910
页数:9
相关论文
共 72 条
[1]   RADICAL CYSTECTOMY FOR STAGE-TA, STAGE-TIS AND STAGE-T1 TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].
AMLING, CL ;
THRASHER, JB ;
FRAZIER, HA ;
DODGE, RK ;
ROBERTSON, JE ;
PAULSON, DF .
JOURNAL OF UROLOGY, 1994, 151 (01) :31-36
[2]   Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: Results of a single center between 1999 and 2002 [J].
Augustin, H ;
Hammerer, P ;
Graefen, M ;
Palisaar, R ;
Noldus, J ;
Fernandez, S ;
Huland, H .
EUROPEAN UROLOGY, 2003, 43 (02) :113-118
[3]   MINIDOSE HEPARIN IN TRANS-URETHRAL PROSTATECTOMY [J].
BEJJANI, BB ;
CHEN, DCP ;
NOLAN, NG ;
EDSON, M .
UROLOGY, 1983, 22 (03) :251-254
[4]  
Bell CRW, 1999, BJU INT, V83, P984
[5]   Thrombelastographic evaluation of coagulation in transurethral prostatectomy [J].
Bell, CRW ;
Cox, DJA ;
Murdock, PJ ;
Sullivan, ME ;
Pasi, KJ ;
Morgan, RJ .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (05) :737-741
[6]  
Benchekroun A, 1998, ANN UROL, V32, P119
[7]   PROPHYLACTIC MINI-DOSE HEPARIN IN PATIENTS UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY - A PROSPECTIVE TRIAL [J].
BIGG, SW ;
CATALONA, WJ .
UROLOGY, 1992, 39 (04) :309-313
[8]  
BROWSE KL, 1974, BRIT J SURG, V61, P19
[9]  
BULKLEY G, 1952, J UROLOGY, V74, P533
[10]   Thrombosis in end-stage renal disease [J].
Casserly, LF ;
Dember, LM .
SEMINARS IN DIALYSIS, 2003, 16 (03) :245-256